Glenmark Pharmaceuticals Launches Lacosamide Injection in USA Targeting $15.2M Market
Glenmark Pharmaceuticals launches Lacosamide Injection USP in the US market, targeting annual sales of $15.2 million. Learn about this strategic portfolio expansion.